View Future GrowthHyperion DeFi 過去の業績過去 基準チェック /06Hyperion DeFiの収益は年間平均-20.1%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間8.8% 64.3%割合で 減少しています。主要情報-20.09%収益成長率18.61%EPS成長率Pharmaceuticals 業界の成長7.33%収益成長率-64.34%株主資本利益率-56.40%ネット・マージン-3,861.93%次回の業績アップデート12 Aug 2026最近の業績更新お知らせ • Jul 29Hyperion DeFi, Inc. to Report Q2, 2026 Results on Aug 12, 2026Hyperion DeFi, Inc. announced that they will report Q2, 2026 results on Aug 12, 2026Reported Earnings • May 20First quarter 2026 earnings released: EPS: US$0.30 (vs US$1.59 loss in 1Q 2025)First quarter 2026 results: EPS: US$0.30 (up from US$1.59 loss in 1Q 2025). Net income: US$3.24m (up US$6.72m from 1Q 2025). Revenue is forecast to grow 53% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in Germany.お知らせ • May 02Hyperion DeFi, Inc. to Report Q1, 2026 Results on May 14, 2026Hyperion DeFi, Inc. announced that they will report Q1, 2026 results Pre-Market on May 14, 2026お知らせ • Mar 17Hyperion DeFi, Inc. to Report Q4, 2025 Results on Mar 26, 2026Hyperion DeFi, Inc. announced that they will report Q4, 2025 results Pre-Market on Mar 26, 2026お知らせ • Nov 16Hyperion Defi, Inc. Reports Unaudited Impairment Charges for the Third Quarter Ended September 30, 2025Hyperion DeFi, Inc. reported unaudited impairment charges for the third quarter ended September 30, 2025. For the quarter, the company reported Impairment loss - digital intangible assets of $6,289,847.お知らせ • Nov 04Hyperion DeFi, Inc. to Report Q3, 2025 Results on Nov 13, 2025Hyperion DeFi, Inc. announced that they will report Q3, 2025 results on Nov 13, 2025すべての更新を表示Recent updatesお知らせ • Jul 29Hyperion DeFi, Inc. to Report Q2, 2026 Results on Aug 12, 2026Hyperion DeFi, Inc. announced that they will report Q2, 2026 results on Aug 12, 2026Reported Earnings • May 20First quarter 2026 earnings released: EPS: US$0.30 (vs US$1.59 loss in 1Q 2025)First quarter 2026 results: EPS: US$0.30 (up from US$1.59 loss in 1Q 2025). Net income: US$3.24m (up US$6.72m from 1Q 2025). Revenue is forecast to grow 53% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in Germany.お知らせ • May 07+ 1 more updateHyperion DeFi, Inc. has filed a Follow-on Equity Offering.Hyperion DeFi, Inc. has filed a Follow-on Equity Offering. Security Name: Common Stock Security Type: Common Stock Security Name: Pre-Funded Warrants Security Type: Equity Warrantお知らせ • May 02Hyperion DeFi, Inc. to Report Q1, 2026 Results on May 14, 2026Hyperion DeFi, Inc. announced that they will report Q1, 2026 results Pre-Market on May 14, 2026お知らせ • Apr 21Hyperion DeFi, Inc., Annual General Meeting, Jun 30, 2026Hyperion DeFi, Inc., Annual General Meeting, Jun 30, 2026.お知らせ • Mar 17Hyperion DeFi, Inc. to Report Q4, 2025 Results on Mar 26, 2026Hyperion DeFi, Inc. announced that they will report Q4, 2025 results Pre-Market on Mar 26, 2026お知らせ • Feb 06Hyperion Defi, Inc. Announces Institutional Volatility Income Vault Built on Rysk ProtocolHyperion DeFi, Inc. announced that it has engaged with the Rysk protocol ("Rysk") to launch a new institutional-grade, on-chain yield-enhancement vault native to the HyperEVM. Through this vault, Hyperion DeFi and its institutional partners will be able to utilize HYPE Liquid Staking tokens (LSTs) and stablecoins as collateral for on-chain options strategies, generating additional yield beyond staking income. Hyperion DeFi will initially deploy the vault for its own balance sheet before selectively opening access to other qualified participants. Participants will be gated through HiHYPE (Hyperion Institutional HYPE), which is minted exclusively by staking staking HYPE to the 'Kinetiq x Hyperion' validator. This structure is designed to create a controlled, institutional-only access model while driving incremental, diversified fee revenue to Hyperion DeFi over time. This new partnership further accelerates the Company's DeFi flywheel, scaling income streams while continuing to position the Company for ecosystem rewards. As of January 2026, more than 37 million HYPE have been autonomously purchased and sequestered by the blockchain with the trading fees generated on the network's central limit order books.お知らせ • Jan 06+ 1 more updateHyperion Defi, Inc. Appoints Robert Rubenstein as General Counsel, Effective January 6, 2026Hyperion DeFi, Inc. announced the appointment of Robert Rubenstein will be joining as General Counsel, effective January 12, 2026. Mr. Rubenstein is a seasoned legal executive with nearly three decades of experience leading legal, compliance, and business development functions for multinational public and private companies. Over his career, he has managed more than $20 billion in complex corporate transactions, overseen global regulatory compliance programs, and directed significant litigation matters in both U.S. and international jurisdictions.お知らせ • Nov 17Hyperion DeFi, Inc. has filed a Follow-on Equity Offering in the amount of $500 million.Hyperion DeFi, Inc. has filed a Follow-on Equity Offering in the amount of $500 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offeringお知らせ • Nov 16Hyperion Defi, Inc. Reports Unaudited Impairment Charges for the Third Quarter Ended September 30, 2025Hyperion DeFi, Inc. reported unaudited impairment charges for the third quarter ended September 30, 2025. For the quarter, the company reported Impairment loss - digital intangible assets of $6,289,847.お知らせ • Nov 04Hyperion DeFi, Inc. to Report Q3, 2025 Results on Nov 13, 2025Hyperion DeFi, Inc. announced that they will report Q3, 2025 results on Nov 13, 2025お知らせ • Sep 30Hyperion Defi, Inc. Announces Appointment of David Knox as Chief Financial Officer, Effective September 29, 2025Hyperion DeFi, Inc. announced the appointment of David Knox, CFA, as Chief Financial Officer, effective September 29, 2025. This move is part of a broader strategic initiative to strengthen governance and accelerate the Company’s decentralized finance (“DeFi”) strategy. Mr. Knox brings with him extensive expertise in scaling capital markets strategies and financial services businesses. He joins Hyperion DeFi from PayPal, where he served as Head of Capital Markets and Head of Finance for Global Credit and Financial Services. In his dual role at PayPal, he led the profitable expansion of the company’s lending segments under a “balance sheet light” strategic imperative and managed core FP&A responsibilities with rigorous governance and reporting across the PayPal and Venmo global financial services platforms. Earlier in his career, Mr. Knox was Director at Cantor Fitzgerald, where he provided capital markets structuring and advisory services across mortgage-backed and asset-backed finance transactions. He also held prior roles in lending and capital markets at SoFi, Hudson Advisors, and the Royal Bank of Scotland. Mr. Knox holds a bachelor’s degree from the University of Connecticut and is an alumnus of the Harvard Business School.お知らせ • Sep 10+ 1 more updateHyperion Defi, Inc. Announces CEO ChangesHyperion DeFi, Inc. announced a series of strategic leadership updates designed to strengthen governance and accelerate its decentralized finance (DeFi) strategy. Mr. Michael Rowe has notified the Company of his intent to resign from his position as Chief Executive Officer of the Company. Pending the effectiveness of Mr. Rowes resignation, Hyunsu Jung, who is currently the Company's Chief Investment Officer and a member of the Board, will serve as Interim Chief Executive Officer. Mr. Jung will be supported by the new Chief Financial Officer, the addition of seasoned blockchain executive Happy Walters to the Company's Board of Directors, and the continued involvement of the Company's strategic advisor, Max Fiege. Collectively, these developments fortify the Companys leadership depth at a pivotal stage of growth and innovation.お知らせ • Sep 09Hyperion DeFi, Inc. Regains Compliance with Nasdaq Listing RequirementsAs previously reported, on April 29, 2025, Hyperion DeFi, Inc. received a notice from the staff of the Nasdaq Stock Market LLC stating that the Company’s stockholders’ equity as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 was below the minimum $2,500,000 required for continued listing under Listing Rule 5550(b)(1). On September 2, 2025, the Company received a notice from the Staff indicating that the Company has regained compliance with the Minimum Equity Requirement.収支内訳Hyperion DeFi の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:B0U 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費31 Mar 261-4019131 Dec 251-4717230 Sep 250-2616330 Jun 250-3618631 Mar 250-42141031 Dec 240-50151430 Sep 240-38161530 Jun 240-37151531 Mar 240-32151331 Dec 230-27141230 Sep 230-25131030 Jun 230-25141031 Mar 230-26141131 Dec 220-28151230 Sep 2210-19151330 Jun 2210-17141331 Mar 2212-15131331 Dec 2114-13121430 Sep 216-20101430 Jun 216-1991431 Mar 214-2081431 Dec 202-2081330 Sep 200-2181330 Jun 200-2071331 Mar 200-2171431 Dec 190-2171430 Sep 190-2271530 Jun 190-2281431 Mar 190-2071331 Dec 180-1761130 Sep 180-135930 Jun 180-103731 Mar 180-73531 Dec 170-51430 Sep 170-41331 Dec 160-413質の高い収益: B0Uは現在利益が出ていません。利益率の向上: B0Uは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: B0Uは利益が出ておらず、過去 5 年間で損失は年間20.1%の割合で増加しています。成長の加速: B0Uの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: B0Uは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 14.5% ) と比較することは困難です。株主資本利益率高いROE: B0Uは現在利益が出ていないため、自己資本利益率 ( -56.4% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/06 19:49終値2026/08/06 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Hyperion DeFi, Inc. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6 アナリスト機関Brett KnoblauchCantor Fitzgerald & Co.Gareth GacettaCantor Fitzgerald & Co.James McIlreeChardan Capital Markets, LLC3 その他のアナリストを表示
お知らせ • Jul 29Hyperion DeFi, Inc. to Report Q2, 2026 Results on Aug 12, 2026Hyperion DeFi, Inc. announced that they will report Q2, 2026 results on Aug 12, 2026
Reported Earnings • May 20First quarter 2026 earnings released: EPS: US$0.30 (vs US$1.59 loss in 1Q 2025)First quarter 2026 results: EPS: US$0.30 (up from US$1.59 loss in 1Q 2025). Net income: US$3.24m (up US$6.72m from 1Q 2025). Revenue is forecast to grow 53% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in Germany.
お知らせ • May 02Hyperion DeFi, Inc. to Report Q1, 2026 Results on May 14, 2026Hyperion DeFi, Inc. announced that they will report Q1, 2026 results Pre-Market on May 14, 2026
お知らせ • Mar 17Hyperion DeFi, Inc. to Report Q4, 2025 Results on Mar 26, 2026Hyperion DeFi, Inc. announced that they will report Q4, 2025 results Pre-Market on Mar 26, 2026
お知らせ • Nov 16Hyperion Defi, Inc. Reports Unaudited Impairment Charges for the Third Quarter Ended September 30, 2025Hyperion DeFi, Inc. reported unaudited impairment charges for the third quarter ended September 30, 2025. For the quarter, the company reported Impairment loss - digital intangible assets of $6,289,847.
お知らせ • Nov 04Hyperion DeFi, Inc. to Report Q3, 2025 Results on Nov 13, 2025Hyperion DeFi, Inc. announced that they will report Q3, 2025 results on Nov 13, 2025
お知らせ • Jul 29Hyperion DeFi, Inc. to Report Q2, 2026 Results on Aug 12, 2026Hyperion DeFi, Inc. announced that they will report Q2, 2026 results on Aug 12, 2026
Reported Earnings • May 20First quarter 2026 earnings released: EPS: US$0.30 (vs US$1.59 loss in 1Q 2025)First quarter 2026 results: EPS: US$0.30 (up from US$1.59 loss in 1Q 2025). Net income: US$3.24m (up US$6.72m from 1Q 2025). Revenue is forecast to grow 53% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in Germany.
お知らせ • May 07+ 1 more updateHyperion DeFi, Inc. has filed a Follow-on Equity Offering.Hyperion DeFi, Inc. has filed a Follow-on Equity Offering. Security Name: Common Stock Security Type: Common Stock Security Name: Pre-Funded Warrants Security Type: Equity Warrant
お知らせ • May 02Hyperion DeFi, Inc. to Report Q1, 2026 Results on May 14, 2026Hyperion DeFi, Inc. announced that they will report Q1, 2026 results Pre-Market on May 14, 2026
お知らせ • Apr 21Hyperion DeFi, Inc., Annual General Meeting, Jun 30, 2026Hyperion DeFi, Inc., Annual General Meeting, Jun 30, 2026.
お知らせ • Mar 17Hyperion DeFi, Inc. to Report Q4, 2025 Results on Mar 26, 2026Hyperion DeFi, Inc. announced that they will report Q4, 2025 results Pre-Market on Mar 26, 2026
お知らせ • Feb 06Hyperion Defi, Inc. Announces Institutional Volatility Income Vault Built on Rysk ProtocolHyperion DeFi, Inc. announced that it has engaged with the Rysk protocol ("Rysk") to launch a new institutional-grade, on-chain yield-enhancement vault native to the HyperEVM. Through this vault, Hyperion DeFi and its institutional partners will be able to utilize HYPE Liquid Staking tokens (LSTs) and stablecoins as collateral for on-chain options strategies, generating additional yield beyond staking income. Hyperion DeFi will initially deploy the vault for its own balance sheet before selectively opening access to other qualified participants. Participants will be gated through HiHYPE (Hyperion Institutional HYPE), which is minted exclusively by staking staking HYPE to the 'Kinetiq x Hyperion' validator. This structure is designed to create a controlled, institutional-only access model while driving incremental, diversified fee revenue to Hyperion DeFi over time. This new partnership further accelerates the Company's DeFi flywheel, scaling income streams while continuing to position the Company for ecosystem rewards. As of January 2026, more than 37 million HYPE have been autonomously purchased and sequestered by the blockchain with the trading fees generated on the network's central limit order books.
お知らせ • Jan 06+ 1 more updateHyperion Defi, Inc. Appoints Robert Rubenstein as General Counsel, Effective January 6, 2026Hyperion DeFi, Inc. announced the appointment of Robert Rubenstein will be joining as General Counsel, effective January 12, 2026. Mr. Rubenstein is a seasoned legal executive with nearly three decades of experience leading legal, compliance, and business development functions for multinational public and private companies. Over his career, he has managed more than $20 billion in complex corporate transactions, overseen global regulatory compliance programs, and directed significant litigation matters in both U.S. and international jurisdictions.
お知らせ • Nov 17Hyperion DeFi, Inc. has filed a Follow-on Equity Offering in the amount of $500 million.Hyperion DeFi, Inc. has filed a Follow-on Equity Offering in the amount of $500 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offering
お知らせ • Nov 16Hyperion Defi, Inc. Reports Unaudited Impairment Charges for the Third Quarter Ended September 30, 2025Hyperion DeFi, Inc. reported unaudited impairment charges for the third quarter ended September 30, 2025. For the quarter, the company reported Impairment loss - digital intangible assets of $6,289,847.
お知らせ • Nov 04Hyperion DeFi, Inc. to Report Q3, 2025 Results on Nov 13, 2025Hyperion DeFi, Inc. announced that they will report Q3, 2025 results on Nov 13, 2025
お知らせ • Sep 30Hyperion Defi, Inc. Announces Appointment of David Knox as Chief Financial Officer, Effective September 29, 2025Hyperion DeFi, Inc. announced the appointment of David Knox, CFA, as Chief Financial Officer, effective September 29, 2025. This move is part of a broader strategic initiative to strengthen governance and accelerate the Company’s decentralized finance (“DeFi”) strategy. Mr. Knox brings with him extensive expertise in scaling capital markets strategies and financial services businesses. He joins Hyperion DeFi from PayPal, where he served as Head of Capital Markets and Head of Finance for Global Credit and Financial Services. In his dual role at PayPal, he led the profitable expansion of the company’s lending segments under a “balance sheet light” strategic imperative and managed core FP&A responsibilities with rigorous governance and reporting across the PayPal and Venmo global financial services platforms. Earlier in his career, Mr. Knox was Director at Cantor Fitzgerald, where he provided capital markets structuring and advisory services across mortgage-backed and asset-backed finance transactions. He also held prior roles in lending and capital markets at SoFi, Hudson Advisors, and the Royal Bank of Scotland. Mr. Knox holds a bachelor’s degree from the University of Connecticut and is an alumnus of the Harvard Business School.
お知らせ • Sep 10+ 1 more updateHyperion Defi, Inc. Announces CEO ChangesHyperion DeFi, Inc. announced a series of strategic leadership updates designed to strengthen governance and accelerate its decentralized finance (DeFi) strategy. Mr. Michael Rowe has notified the Company of his intent to resign from his position as Chief Executive Officer of the Company. Pending the effectiveness of Mr. Rowes resignation, Hyunsu Jung, who is currently the Company's Chief Investment Officer and a member of the Board, will serve as Interim Chief Executive Officer. Mr. Jung will be supported by the new Chief Financial Officer, the addition of seasoned blockchain executive Happy Walters to the Company's Board of Directors, and the continued involvement of the Company's strategic advisor, Max Fiege. Collectively, these developments fortify the Companys leadership depth at a pivotal stage of growth and innovation.
お知らせ • Sep 09Hyperion DeFi, Inc. Regains Compliance with Nasdaq Listing RequirementsAs previously reported, on April 29, 2025, Hyperion DeFi, Inc. received a notice from the staff of the Nasdaq Stock Market LLC stating that the Company’s stockholders’ equity as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 was below the minimum $2,500,000 required for continued listing under Listing Rule 5550(b)(1). On September 2, 2025, the Company received a notice from the Staff indicating that the Company has regained compliance with the Minimum Equity Requirement.